enbucrilate has been researched along with Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korsic, S; Popovic, P; Skok, P; Stabuc, B | 1 |
| Cho, SW; Hwang, JC; Jung, JY; Kim, JH; Kim, YB; Lee, KM; Sin, SJ; Yoo, BM | 1 |
2 other study(ies) available for enbucrilate and Hepatic Failure
| Article | Year |
|---|---|
TIPS
Topics: Cause of Death; Enbucrilate; Endoscopy; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypertension, Portal; Liver Failure; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Recurrence; Retrospective Studies; Sclerosing Solutions; Secondary Prevention; Stents | 2021 |
Hepatic failure requiring transplantation caused by portal vein embolism as a complication of N-buty-2-cyanoacrylate injection for a bleeding gastric varix.
Topics: Embolism; Enbucrilate; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Injections, Intralesional; Liver Failure; Liver Transplantation; Male; Middle Aged; Portal Vein | 2009 |